Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
Author:
- 28 December 2012
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 28 (s2) , 52-59
Abstract
Summary: Obesity, hypertension, insulin resistance (IR), dyslipidaemia, impaired coagulation profile and chronic inflammation characterize cardiovascular risk factors in men. Adipose tissue is an active endocrine organ producing substances that suppress testosterone (T) production and visceral fat plays a key role in this process. Low T leads to further accumulation of fat mass, thus perpetuating a vicious circle. In this review, we discuss reduced levels of T and increased cardiovascular disease (CVD) risk factors by focusing on evidence derived from three different approaches. (i) epidemiological/ observational studies (without intervention); (ii) androgen deprivation therapy (ADT) studies (standard treatment in advanced prostate cancer); and (iii) T replacement therapy (TRT) in men with T deficiency (TD). In epidemiological studies, low T is associated with obesity, inflammation, atherosclerosis and the progression of atherosclerosis. Longitudinal epidemiological studies showed that low T is associated with an increased cardiovascular mortality. ADT brings about unfavourable changes in body composition, IR and dyslipidaemia. Increases in fibrinogen, plasminogen activator inhibitor 1 and C‐reactive protein have also been observed. TRT in men with TD has consistently shown a decrease in fat mass and simultaneous increase in lean mass. T is a vasodilator and in long‐term studies, it was shown to reduce blood pressure. There is increasing evidence that T treatment improves insulin sensitivity and lipid profiles. T may possess anti‐inflammatory and anti‐coagulatory properties and therefore TRT contributes to reduction of carotid intima media thickness. We suggest that T may have the potential to decrease CVD risk in men with androgen deficiency.Keywords
This publication has 96 references indexed in Scilit:
- Exogenous Testosterone, Cardiovascular Events, and Cardiovascular Risk Factors in Elderly Men: A Review of Trial DataThe Journal of Sexual Medicine, 2012
- Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic WomenDiabetes Care, 2011
- Endogenous Testosterone, Endothelial Dysfunction, and Cardiovascular Events in Men with Nondialysis Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 DiabetesDiabetes Care, 2011
- Testosterone replacement therapy and cardiovascular risk factors modificationThe Aging Male, 2011
- Low Free Testosterone is Associated with Heart Failure Mortality in Older Men Referred for Coronary AngiographyEuropean Journal of Heart Failure, 2011
- Testosterone, cardiovascular disease and the metabolic syndromeBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- Low serum testosterone, arterial stiffness and mortality in male haemodialysis patientsNephrology Dialysis Transplantation, 2011
- Low Serum Testosterone Is Associated with Increased Mortality in Men with Stage 3 or Greater NephropathyAmerican Journal of Nephrology, 2011
- The association of hypotestosteronemia with coronary artery disease in men.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994